RA Today: The Outlook Improves, A Clinical Context ReportMedPage TodayNumerous treatment options for RA exist, including non-steroidal anti-inflammatory drugs, methotrexate, plaquenil, sulfasalazine, steroids, tumor necrosis factor inhibitors, and ritu…
Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative … – Stockhouse
Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative …StockhouseHUMIRA is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional t…
Review of Research with Chimpanzee Models Points to Few Areas of Need – Genetic Engineering News
Review of Research with Chimpanzee Models Points to Few Areas of NeedGenetic Engineering NewsRituximab, which treats B-cell non-Hodgkin lymphoma, and Remicaid, approved for several inflammatory and arthritic conditions, were tested in chimpanzees. Asid…
Organ donor gave Colin life – Byron Shire News
Fox 13 Now – Salt Lake CityOrgan donor gave Colin lifeByron Shire NewsNor would he have seen his daughter grow into a beautiful young woman now attending university, had it not been for one family's decision to fulfil their loved one's wish of …
Cadaver organ donation – DAWN.com
Cadaver organ donationDAWN.comLAST week, the Sindh Institute of Urology and Transplant and the Transplant Society of Pakistan observed Organ Donation Day in an appeal to people to give others a new lease of life. Doctors estimate that up to 50000 lives…
Biologic Fails in Kidney Disorder – MedPage Today
Biologic Fails in Kidney DisorderMedPage TodayThe addition of rituximab (Rituxan) to a standard immunosuppressive regimen failed to increase the overall response rate among patients with lupus nephritis. Note that adverse event rates overall were simil…
Biogen Idec Gearing Up For Major Launches – Seeking Alpha
Biogen Idec Gearing Up For Major LaunchesSeeking AlphaBiogen also benefits from the fact that two of its potential competitors – daclizumab and ocrelizumab – are partnered programs with Abbott (ABT) and Roche (RHHBY.PK), respectively, and Biogen contro…
Mortality Risk in Heart Failure No Higher with Losartan – MedPage Today
Mortality Risk in Heart Failure No Higher with LosartanMedPage TodayNote that angiotensin II receptor blockers as a class are currently recommended for use in patients with heart failure who are intolerant of ACE inhibitors. However, some observational…
Common Blood Pressure Drug Safe for Heart Failure: Study – U.S. News & World Report
Common Blood Pressure Drug Safe for Heart Failure: StudyU.S. News & World ReportBy Steven Reinberg TUESDAY, April 10 (HealthDay News) — Although research has suggested that the blood pressure drug losartan (Cozaar) may be tied to an increased risk of …
ACR Updates RA Advice on DMARDS, Biologics, Switching Drugs – Medscape
ACR Updates RA Advice on DMARDS, Biologics, Switching DrugsMedscapeDr. Singh pointed to 4 major changes from the 2008 ACR recommendations: The 2012 recommendations cover 3 additional biologics (certolizumab, tocilizumab, and golimumab) in addition to a…